Follow
Vignesh Sivaganesh, PhD
Vignesh Sivaganesh, PhD
SJU and PCOM
Verified email at pcom.edu - Homepage
Title
Cited by
Cited by
Year
A network of conserved synthetic lethal interactions for exploration of precision cancer therapy
R Srivas, JP Shen, CC Yang, SM Sun, J Li, AM Gross, J Jensen, K Licon, ...
Molecular cell 63 (3), 514-525, 2016
1602016
Diet and feeding pattern modulate diurnal dynamics of the ileal microbiome and transcriptome
ACD Machado, SD Brown, A Lingaraju, V Sivaganesh, C Martino, A Chaix, ...
Cell reports 40 (1), 2022
382022
Protein tyrosine phosphatases: mechanisms in cancer
V Sivaganesh, V Sivaganesh, C Scanlon, A Iskander, S Maher, T Lê, ...
International Journal of Molecular Sciences 22 (23), 12865, 2021
252021
Emerging immunotherapies against novel molecular targets in breast cancer
V Sivaganesh, N Promi, S Maher, B Peethambaran
International Journal of Molecular Sciences 22 (5), 2433, 2021
162021
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition
JP Shen, R Srivas, A Gross, J Li, EJ Jaehnig, SM Sun, ...
Oncotarget 6 (34), 35755, 2015
142015
Structure–activity relationship of 2-aminodibenzothiophene pharmacophore and the discovery of aminobenzothiophenes as potent inhibitors of Mycobacterium smegmatis
SH Alelaiwi, JE Heindl, V Sivaganesh, B Peethambaran, JR McKee
Bioorganic & Medicinal Chemistry Letters 63, 128650, 2022
32022
The Role of ROR1 in Targeted Prostate Cancer Treatment and Malignant Progression
V Sivaganesh
Saint Joseph's University, 2023
12023
RAD17 loss of function is synthetically lethal with the checkpoint kinase inhibitors AZD7762 or MK-1775
JP Shen, R Srivas, A Bojorquez-Gomez, K Licon, V Sivaganesh, JL Xu, ...
Cancer Research 75 (15_Supplement), 129-129, 2015
12015
Penta-O-galloyl-ꞵ-D-glucose (PGG) targets aggressive androgen independent prostate cancer by ROR1 inhibition
V Sivaganesh, A Iskander, T Ta, B Peethambaran
Molecular Biology of the Cell 34 (2), 2023
2023
Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer
V Sivaganesh, B Peethambaran
Exploration of Targeted Anti-tumor Therapy 4 (6), 1188, 2023
2023
Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) as a Selective Molecular Target in Androgen‐Dependent and Androgen‐Independent Prostate Cancer
V Sivaganesh, N Promi, S Maher, B Peethambaran
The FASEB Journal 35, 2021
2021
Inhibiting ROR1 expression in Androgen-Independent Prostate Cancer Reduces Aggressive Cancer Phenotypes by modulation of AKT-GSK3ꞵ Pathway
V Sivaganesh, N Promi, S Maher, B Peethambaran
2021
350–Gwas-Identified Metabolic Syndrome Genes are Tightly Linked to Race
N Easwar, SD Brown, A Desalermos, V Sivaganesh, AS Parnell, A Rajput, ...
Gastroenterology 156 (6), S-71, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–13